Clinical Drug Experience Knowledgebase

azacitidine (vidaza) (1 trial)

bendamustine (treanda) (5 trials)

cyclophosphamide (cytoxan) (11 trials)

cytarabine (cytosar-u) (4 trials)

doxorubicin (Doxil) (14 trials)

gemcitabine (gemzar) (5 trials)

lenalidomide (revlimid) (10 trials)

prednisone (meticorten) (12 trials)

rituximab (rituxan) (17 trials)

romidepsin (istodax) (3 trials)

urea (4 trials)

vincristine (oncovin) (11 trials)

vindesine (Eldisine) (1 trial)

atezolizumab (Tecentriq) (2 trials)

axicabtagene ciloleucel (Yescarta) (1 trial)

bleomycin (blenoxane) (2 trials)

brentuximab vedotin (adcetris) (5 trials)

carboplatin (paraplatin) (1 trial)

carmustine (bicnu) (1 trial)

cisplatin (platinol) (2 trials)

dacarbazine (dtic-dome) (2 trials)

entospletinib (1 trial)

etoposide (vepesid) (4 trials)

fludarabine (fludara) (1 trial)

glofitamab (1 trial)

ibrutinib (imbruvica) (3 trials)

ifosfamide (ifex) (2 trials)

inotuzumab ozogamicin (besponsa) (1 trial)

iph4102 (1 trial)

melphalan (alkeran) (1 trial)

nivolumab (opdivo) (1 trial)

obinutuzumab (gazyva) (4 trials)

ofatumumab (arzerra) (1 trial)

oxaliplatin (eloxatin) (3 trials)

pixuvri (1 trial)

procarbazine (matulane) (1 trial)

ruxolitinib (jakafi) (1 trial)

sargramostim (leukine) (1 trial)

tafasitamab (Monjuvi) (1 trial)

tazemetostat (Tazverik) (1 trial)

temsirolimus (torisel) (1 trial)

valemetostat (1 trial)

venetoclax (venclexta) (2 trials)

vinblastine (velban) (4 trials)

vismodegib (erivedge) (1 trial)

everolimus (zortress) (1 trial)

mpeg-r-crisantaspase (1 trial)

selicrelumab (1 trial)

selinexor (Xpovio) (1 trial)

spebrutinib (1 trial)